FIELD: medicine, phthisiology, pharmacology. SUBSTANCE: invention relates to the combined antituberculosis preparation. The combined antituberculosis preparation comprises rifampicin, ethambutol, isoniazide, pyrazinamide and pyridoxine taken in the definite ratio of components. Invention provides the enhancement of effectiveness of therapy due to simplification of curative process, resistance overcoming in many patients and improvement of the preparation properties. EFFECT: enhanced effectiveness of preparation and treatment. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
USE OF NANOPHOSPHOLIPID COMPOSITION OF RIFAMPICINE TOGETHER WITH PROTIONAMIDE OR ITS NANOPHOSPHOLIPID FORM IN TREATMENT OF TUBERCULOSIS | 2014 |
|
RU2595881C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
Authors
Dates
2003-01-10—Published
2002-02-06—Filed